Finch Therapeutics Group, Inc. Common Stock
FNCH
FNCH was delisted on the 24th of May, 2024.
11 hedge funds and large institutions have $338K invested in Finch Therapeutics Group, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 6 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
35% less funds holding
Funds holding: 17 → 11 (-6)
55% less capital invested
Capital invested by funds: $755K → $338K (-$417K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.29K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$301 |
| 3 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$243K |
| 2 |
Renaissance Technologies
New York
|
-$42K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$509 |
| 5 |
Morgan Stanley
New York
|
-$251 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $155K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $94.3K | -$7K | -2,512 | -6% |
|
|
LSAG
3
Lake Street Advisors Group
Portsmouth,
New Hampshire
| $55.7K | – | – | – |
|
|
IC
4
Ikarian Capital
Dallas,
Texas
| $18.1K | – | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $10.8K | +$4.29K | +1,537 | +59% |
|
|
BL
6
Bleichroeder LP
New York
| $2.52K | – | – | – |
|
7
BlackRock
New York
| $850 | -$39 | -14 | -4% |
|
|
8
Morgan Stanley
New York
| $406 | -$251 | -90 | -37% |
|
|
9
UBS Group
Zurich,
Switzerland
| $286 | +$301 | +108 | +5,400% |
|
|
10
Wells Fargo
San Francisco,
California
| $18 | +$3 | +1 | +17% |
|
|
BG
11
Baupost Group
Boston,
Massachusetts
| – | -$243K | -67,296 | Closed |
|
|
12
Renaissance Technologies
New York
| – | -$42K | -11,746 | Closed |
|
|
13
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$509 | -141 | Closed |
|
14
Bank of America
Charlotte,
North Carolina
| – | -$43 | -12 | Closed |
|
|
MFT
15
Moisand Fitzgerald Tamayo
Orlando,
Florida
| – | -$11 | -3 | Closed |
|
FNCH Hedge Fund Activity: Q1 2024 in Review
11 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Finch Therapeutics Group, Inc. Common Stock (FNCH) for Q1 2024, worth a combined $338K — down 55% from $755K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of FNCH and 0 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $4.29K. The largest seller was Baupost Group, exiting entirely with an estimated $243K sold.
- 11 institutional investors held Finch Therapeutics Group, Inc. Common Stock (FNCH) as of Q1 2024, down from 17 in Q4 2023.
- Funds reported $338K of Finch Therapeutics Group, Inc. Common Stock stock for Q1 2024, down 55% quarter-over-quarter.
- 0 funds opened new Finch Therapeutics Group, Inc. Common Stock positions in Q1 2024 and 6 closed out, a net change of -6 holders.
- The largest Finch Therapeutics Group, Inc. Common Stock buyer in Q1 2024 was Tower Research Capital (TRC), an estimated $4.29K added.
- The largest Finch Therapeutics Group, Inc. Common Stock seller in Q1 2024 was Baupost Group, an estimated $243K sold.
Based on aggregated 13F filings for Q1 2024.